The Food and Drug Administration approved Papzimeos (zopapogene imadenovec-drba) for the treatment of adults with recurrent ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

With the FDA’s go-ahead, Coya plans to launch a multicenter phase 2 trial of COYA 302 in patients with ALS, CEO Arun ...

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its ...

There have been 4 new reports of serious adverse events related to Ixchiq based on updated Vaccine Adverse Event Reporting System data.

A. The Food and Drug Administration has approved montelukast to treat asthma, exercise-induced bronchoconstriction (trouble ...

Drugmaker Novo Nordisk received accelerated approval for the drug’s use in people with moderate to advanced liver scarring, ...

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

On Tuesday, the Food and Drug Administration (FDA) warned consumers about potential contamination of a well-known brand of ...

Austin, Texas, United States, August 25th, 2025, FinanceWire NRx Pharmaceuticals has filed a Citizen Petition with the FDA to ...

The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.